Abstract:Background: Sarcosine is an amino acid that is formed by methylation of glycine and is present in trace amounts in the body. Increased sarcosine concentrations in blood plasma and urine are manifested in sarcosinemia and in some other diseases such as prostate cancer. For this purpose, sarcosine detection using the nanomedicine approach was proposed. In this study, we have prepared superparamagnetic iron oxide nanoparticles (SPIONs) with different modified surface area. Nanoparticles (NPs) were modified by chitosan (CS), and sarcosine oxidase (SOX). SPIONs without any modification were taken as controls. Methods and Results: The obtained NPs were characterized by physicochemical methods. The size of the NPs determined by the dynamic light scattering method was as follows: SPIONs/Au/NPs (100–300 nm), SPIONs/Au/CS/NPs (300–700 nm), and SPIONs/Au/CS/SOX/NPs (600–1500 nm). The amount of CS deposited on the NP surface was found to be 48 mg/mL for SPIONs/Au/CS/NPs and 39 mg/mL for SPIONs/Au/CS/SOX/NPs, and repeatability varied around 10%. Pseudo-peroxidase activity of NPs was verified using sarcosine, horseradish peroxidase (HRP) and 3,3′,5,5′-tetramethylbenzidine (TMB) as a substrate. For TMB, all NPs tested evinced substantial pseudo-peroxidase activity at 650 nm. The concentration of SPIONs/Au/CS/SOX/NPs in the reaction mixture was optimized to 0–40 mg/mL. Trinder reaction for sarcosine detection was set up at 510 nm at an optimal reaction temperature of 37 °C and pH 8.0. The course of the reaction was linear for 150 min. The smallest amount of NPs that was able to detect sarcosine was 0.2 mg/well (200 μL of total volume) with the linear dependence y = 0.0011x − 0.0001 and the correlation coefficient r = 0.9992, relative standard deviation (RSD) 6.35%, limit of detection (LOD) 5 μM. The suggested method was further validated for artificial urine analysis (r = 0.99, RSD 21.35%, LOD 18 μM). The calculation between the detected and applied concentrations showed a high correlation coefficient (r = 0.99). NPs were tested for toxicity and no significant growth inhibition was observed in any model system (S. cerevisiae, S. aureus, E. coli). The hemolytic activity of the prepared NPs was similar to that of the phosphate buffered saline (PBS) control. The reaction system was further tested on real urine specimens. Conclusion: The proposed detection system allows the analysis of sarcosine at micromolar concentrations and to monitor changes in its levels as a potential prostate cancer marker. The whole system is suitable for low-cost miniaturization and point-of-care testing technology and diagnostic systems. This system is simple, inexpensive, and convenient for screening tests and telemedicine applications.

A highly sensitive Zr-MOFs mediated multi-enzyme cascade platform for the colorimetric and fluorescent dual-signal determination of sarcosine

Fluorescence and Colorimetric Dual-mode Multienzyme Cascade Nanoplatform Based on CuNCs/FeMn-ZIF-8/PCN for Detection of Sarcosine

2D Fe/Co-MOF/SOX cascade reactors for fast noninvasive detection of sarcosine level in prostate cancer urine

Construction of NM88B(Fe)-POR/Rf equipped with hyperoxia microenvironment as a cascade nanozyme for ultrasensitive electrochemical detection of sarcosine

Dual-mode fluorescence and colorimetric smartphone-based sensing platform with oxidation-induced self-assembled nanoflowers for sarcosine detection

An intelligent ratiometric fluorescent assay based on MOF nanozyme-mediated tandem catalysis that guided by contrary logic circuit for highly sensitive sarcosine detection and smartphone-based portable sensing application

Using bimetallic Au/Cu nanoplatelets for construction of facile and label-free inner filter effect-based photoluminescence sensing platform for sarcosine detection

A Rapid Method for the Detection of Sarcosine Using SPIONs/Au/CS/SOX/NPs for Prostate Cancer Sensing

Nanoreactor of sarcosine oxidase-embedded ZIFs activates fluorescent response for diagnosis of prostate cancer

Colorimetric determination of sarcosine in human urine with enzyme-like reaction mediated Au nanorods etching

Colorimetric determination of sarcosine in urine samples of prostatic carcinoma by mimic enzyme palladium nanoparticles

Electrochemical sensor based on super-magnetic metal–organic framework@molecularly imprinted polymer for Sarcosine detection in urine

Intelligent Screening of Prostate Cancer Individuals Using an Enzyme‐Assisted Multicolor Visualization Platform

Ratiometric fluorescence sensor and smartphone-based microfluidic sensing platform based on oxidation induced Ce(III)/Ce(IV) phosphatase-like activity and complexation effect activation for sarcosine detection

Determination of sarcosine based on magnetic cross-linked enzyme aggregates for diagnosis of prostate cancer

Distance-based analytical device integrated with carbon nanomaterials for sarcosine quantification in human samples

Photothermal biosensing integrated with microfluidic paper-based analytical device for sensitive quantification of sarcosine

Aptasensor based on high surface area covalent organic framework for simple and ultrasensitive detection of sarcosine in the diagnosis of prostate cancer

New autonomous and self-signaling biosensing device for sarcosine detection

Graphenoxide Cross-Linker Based Potentiometric Biosensor Design for Sarcosine Determination

A molecularly imprinting photoelectrochemical sensor based on Bi2O2S-sensitized perovskite Cs2AgBiBr6 for sarcosine determination